SCHEMBL9325100

SCHEMBL9325100

COC(=O)c1ccc(C(c2ccccc2)C2C(NCc3ccccc3)C3CCN2CC3)cc1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 14/20 0.73
CACNA1F O60840 1/20 0.60
CHRM5 P08912 1/20 0.60
CACNA1D Q01668 1/20 0.60
CACNA1S Q13698 1/20 0.60
CACNA1C Q13936 1/20 0.60
TMEM97 Q5BJF2 1/20 0.60
GPR65 Q8IYL9 1/20 0.60
KCNK9 Q9NPC2 1/20 0.58
KDM4E B2RXH2 1/20 0.58
MEN1 O00255 1/20 0.58
GMNN O75496 1/20 0.58
LMNA P02545 1/20 0.58
PMP22 Q01453 1/20 0.58
KMT2A Q03164 1/20 0.58
CYP2D6 P10635 1/20 0.58
ATM Q13315 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9325087 1.00 TACR1 (0.73) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9325094 1.00 TACR1 (0.73) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL10380498 1.00 TACR1 (0.73) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9322893 0.97 TACR1 (0.74) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9322897 0.97 TACR1 (0.74) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9322487 0.90 TACR1 (0.72) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9322473 0.90 TACR1 (0.72) TACR1CACNA1FCHRM5CACNA1DCACNA1S
SCHEMBL9322560 0.89 TACR1 (0.80) TACR1KCNK9KDM4EMEN1GMNN
SCHEMBL9322552 0.89 TACR1 (0.80) TACR1KCNK9KDM4EMEN1GMNN
SCHEMBL9322565 0.89 TACR1 (0.80) TACR1KCNK9KDM4EMEN1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
EP-0409931-A1 QUINUCLIDINE THERAPEUTIC AGENTS. PFIZER (US) 1991-01-30 EP disclosed
WO-1990005729-A1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER INC. (US) 1990-05-31 WO disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed